|
|
|
|
Generic Names of Some Trade Name Drugs, THE MERCK MANUAL OF HEALTH & AGING
Committed to Providing Medical Information Table of Contents Index Enlarge Text Reset Text Shrink Text -- Buy the Book Learn about participating in clinical trials at this government website: www.clinicaltrials.gov - APPENDIX I - Drug Names: Generic and Trade TOPICS - Introduction -~ Some Trade Names of Generic Drugs -~ Generic Names of Some Trade Name Drugs - Generic Names of Some...
|
|
|
Some Trade Names of Generic Drugs, THE MERCK MANUAL OF HEALTH & AGING
Committed to Providing Medical Information Table of Contents Index Enlarge Text Reset Text Shrink Text -- Buy the Book Learn about participating in clinical trials at this government website: www.clinicaltrials.gov - APPENDIX I - Drug Names: Generic and Trade TOPICS - Introduction -~ Some Trade Names of Generic Drugs-~ Generic Names of Some Trade Name Drugs - Some Trade Names of...
|
|
|
Novartis Annual Report 2002
Looking for answers Search Home Financial highlights Letter from Daniel Vasella Amazing Patient Stories...
Primary Care includes a wide range of products for the treatment of cardiovascular diseases, central nervous system disorders and dermatological conditions (including fungal infections, eczema, psoriasis and genital herpes).
Backed by the Val-Heft study data showing...
|
|
|
Pharmaceutical Product List I-L - Novartis.com
Search Novartis.com - Go Novartis.com Home Products Pharmaceutical Best Sellers Pharmaceuticals CIBA Vision Animal Health Over the Counter Infant and Baby Medical Nutrition Diseases & Conditions About Novartis Investor Relations Media Relations Careers Corporate Citizenship Business Development Our Mission Our Businesses Leadership & Governance Research & Development Foundations...
|
|
|
Pharmaceutical Best Sellers: Top 10 Products - Novartis.com
Search Novartis.com - Go Novartis.com Home Products Pharmaceutical Best Sellers Pharmaceuticals CIBA Vision Animal Health Over the Counter Infant and Baby Medical Nutrition Diseases & Conditions About Novartis Investor Relations Media Relations Careers Corporate Citizenship Business Development Our Mission Our Businesses Leadership & Governance Research & Development Foundations...
|
|
|
Novartis products for heart disease, cancer and more - Novartis.com
Search Novartis.com - Go Novartis.com Home Products Pharmaceutical Best Sellers Pharmaceuticals CIBA Vision Animal Health Over the Counter Infant and Baby Medical Nutrition Diseases & Conditions About Novartis Investor Relations Media Relations Careers Corporate Citizenship Business Development Our Mission Our Businesses Leadership & Governance Research & Development Foundations...
|
|
|
THE MERCK MANUAL OF GERIATRICS, App. III, Trade Names of Some Commonly Used Drugs, GANTANOL to LYSODREN
Trade Names of Some Commonly Used Drugs TRADE AND GENERIC NAMES OF COMMONLY USED DRUGS GANTANOL to LYSODREN Trade Name Generic GANTANOL Sulfamethoxazole GANTRISIN Sulfisoxazole GARAMYCIN Gentamicin GEOCILLIN Carbenicillin GLUCOPHAGE Metformin GLUCOTROL Glipizide GRIFULVIN V Griseofulvin GRISACTIN Griseofulvin HALCION Triazolam HALDOL Haloperidol HALDRONE Paramethasone HALOTESTIN...
|
|
|
THE MERCK MANUAL OF GERIATRICS, App. III, Trade Names of Some Commonly Used Drugs, Factor IX concentrates to Itraconazole
Trade Names of Some Commonly Used Drugs GENERIC AND TRADE NAMES OF COMMONLY USED DRUGS Factor IX concentrates to Itraconazole Generic Trade Name Factor IX concentrates KONYNE 80, PROPLEX T Famciclovir FAMVIR Famotidine PEPCID Felodipine PLENDIL Fenfluramine PONDIMIN Fenoprofen NALFON Fentanyl SUBLIMAZE Fexofenadine ALLEGRA Filgrastim NEUPOGEN Finasteride PROSCAR, PROPECIA Flavoxate...
|
|
|
Latest News
Stock Watch Earnings Estimate Fundamentals Shareholder Reports Webcasts Regulatory Filings Corporate Governance Executive Team Affiliated Companies Press Room Analysts Request Investor Information Biovail Enters Into a Co-Promotion Arrangement With Reliant Pharmaceuticals TORONTO, Oct 29, 2002 (BUSINESS WIRE) -- Biovail Corporation (NYSE, TSX: BVF) announced today that it has entered...
|
|
|
Statins for high cholesterol - [Medication] - Quest Diagnostics Patient Health Library
Topic Contents - Examples - How It Works - Why It Is Used - How Well It Works - Side Effects - What To Think About - References Statins for high cholesterol - [Medication] - Quest Diagnostics Patient Health Library Statins for high cholesterol - [Medication] - Quest Diagnostics Patient Health Library Blood and lymph, Disease and injury prevention, Heart and circulation,...
|
|
|
Should I take statins for high cholesterol? - Quest Diagnostics Patient Health Library
Should I take statins for high cholesterol?
Guidelines from the U.S.
For some people, quitting smoking, reducing blood pressure, losing weight, or getting more exercise can have the same or greater impact on reducing the risk of heart disease than taking medicine.
Have diabetes.
Statins are proven to lower the risk of heart attack, stroke, and death in people with high...
|
|
|
Advances in the Treatment of Cardiovascular Diseases
Pg 227A:1010-147) Fluvastatin (Lescol®, Novartis) A new analysis of data from the LIPS (Lescol Intervention Prevention Study) indicates that early fluvastatin treatment in a post-percutaneous coronary intervention (PCI) population with average cholesterol levels reduced the risk of major adverse cardiovascular events (MACE), irrespective of whether...
author: BioPortfolio - Knowledge Management, Market Analysis and Market Research
|
|
|
Advances in the Treatment of Cardiovascular Diseases
Pg 227A:1010-147) Fluvastatin (Lescol®, Novartis) A new analysis of data from the LIPS (Lescol Intervention Prevention Study) indicates that early fluvastatin treatment in a post-percutaneous coronary intervention (PCI) population with average cholesterol levels reduced the risk of major adverse cardiovascular events (MACE), irrespective of whether...
author: BioPortfolio - Knowledge Management, Market Analysis and Market Research
|
|
|
bfw07182005.qxd page 2
author: RobbinsJ
|
|
|
MEDMONITOR - Pearls from Recent Medical Journals and Conferences (2/4/02)
- - - - BioNews BioWeb Companies Products BioReports - - - - - - Btech News - MEDMONITOR - Pearls from Recent Medical Journals and Conferences (2/4/02) NATURE, January 31, 2002; 415:484-485, 530-536: DNA microarrays can be used to distinguish between more versus less aggressive breast cancers.
-- AMERICAN JOURNAL OF KIDNEY DISEASES, January 2002; 39:67-75: Treatment with Novartis...
|
|
|
MEDMONITOR - Pearls from Recent Medical Journals and Conferences (11/2/02)
- - - - BioNews BioWeb Companies Products BioReports - - - - - - MEDMONITOR - Pearls from Recent Medical Journals and Conferences (11/2/02) LANCET, Feb.
Second, if developed properly, the test could vastly improve the diagnosis and treatment of ovarian cancer.
Clinical trial data from fifteen clinical studies involving more than 3,700 patients suggests that its magnitude of...
|
|
|
A Statin A Day Keeps the Doctor Away
- - - - BioNews BioWeb Companies Products BioReports - - - - - A Statin A Day Keeps the Doctor Away Lescol Intervention Prevention Study (LIPS) investigators, led by Dr.
Serruys (Rotterdam, the Netherlands), discovered that Lescol (fluvastatin) therapy significantly reduced major adverse cardiac event risk following successful initial percutaneous coronary...
|
|
|
BioPortfolio Limited
22 Benchmarking relative performance across ‘switch and grow’ reformulations 23 Benchmarking absolute performance across ‘switch and grow’ reformulations 24 Benchmarking return on investment across ‘switch and grow’ reformulations 27 CHAPTER 2 TACTICAL AND STRATEGIC OBJECTIVES FOR PRODUCT REFORMULATION 32 Key findings 32 The tactical objectives of drug...
|
|
|
BioPortfolio Limited
30 Main types of dyslipidemia 31 Hypercholesterolemia 31 Familial hypercholesterolemia 31 Mixed dyslipidemia 32 Hypertriglyceridemia 32 Familial hypertriglyceridemia 32 Epidemiology overview 33 Prevalence of dyslipidemia 33 Methodology 35 US 35 Japan 36 France 37 Germany 37 Italy 37 Spain 38 UK 39 Lipitor: the gold standard in the treatment of dyslipidemia 39 Associated...
|
|
|
Medivir: News
“In less than two years, we have successfully implemented the first phase of our business plan, with the acquisition of marketed products, like Axid® and DynaCirc®, and the agreement to promote the Lescol® brand, as well as the second phase, with the filing of two New Drug Applications with the FDA for internally developed formulations of proven molecules&...
|
|
|
402_12780.qxd
ALT° AST (GPT° GOT) Alanine Aminotransferase (Glutamate Pyruvate Transaminase) and Aspartate Aminotransferase (Glutamate Oxaloacetate Transaminase) Test Cassette REF 12- 788 CLIA- WAIVEDN These tests are waived under CLIA '88 regulations.
The Lot number and Expiration date are also contained on the stripe.
Calibration No calibration is done by the user.
Der...
|
|
|
402_12780.qxd page 3
|
|
|
Novartis Press Kit English page 10
author: guestnc1
duplicates:
http://www.novartis.com/downloads/press_kit.pdf
|
|
|
http://www.fda.gov/cder/orange/appendix_a.txt
ACTHAR GEL, CORTICOTROPIN H.R.-50, HYDROCHLOROTHIAZIDE HABITROL, NICOTINE (OTC) HALCION, TRIAZOLAM HALDOL SOLUTAB, HALOPERIDOL HALDOL, HALOPERIDOL HALDOL, HALOPERIDOL DECANOATE HALDOL, HALOPERIDOL LACTATE HALDRONE, PARAMETHASONE ACETATE HALFAN, HALOFANTRINE HYDROCHLORIDE HALOG, HALCINONIDE HALOG-E, HALCINONIDE HALOPERIDOL DECANOATE, HALOPERIDOL DECANOATE HALOPERIDOL INTENSOL,...
|
|
|
EFFICACY SUPPLEMENTS APPROVED IN CALENDAR YEAR 2003
FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER - Search - - EFFICACY SUPPLEMENTS APPROVED IN CALENDAR YEAR 2003 (SE1 -SE7)* and EFFICACY SUPPLEMENTS APPROVED IN CALENDAR YEAR 2003 (SE8)* - GENERIC NAME APPLICANT NDA NUMBER SUPP TYPE SUPP NUMBER RECEIPT DATE APPROVAL DATE PRIORITY REVIEW TOTAL APPROVAL TIME (MONTHS) INDICATION/DESCRIPTION FLUOXETINE...
|
